HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 572 participants.
Also called NCT02073565
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 572 participants
- Registry
-
NCT02073565
-
- Main results
- Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-eluting stent in patients with ischaemic coronary disease and non-ST-elevation acute coronary syndrome
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Japan
- Registry status
- Completed
Technical summary
Registry record NCT02073565. Randomized; single masking; primary purpose treatment. Start 2014-02 (registry gives no type); primary completion 2017-07-14 (actual). Results posted on 2018-11-21.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt
- Acronym
- HARMONEE
- Condition
- Coronary Arteriosclerosis
- Condition
- Non ST Segment Elevation Acute Coronary Syndrome
- Intervention (Device)
- OrbusNeich Combo stent™
- Intervention (Device)
- Everolimus Eluting Stent (EES)
- Lead sponsor
- OrbusNeich
- Collaborator
- OrbusNeich Medical K.K.
- Collaborator
- Duke Clinical Research Institute
Record details
- Record id
cardio:ct-nct02073565- Content hash
5fbd73af01a0afc4bbeb066a3765262c95a994f1d1b048f64bd8d9114741d52d